Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Human Clinical Data (20242025): While much of the early data was preclinical, a 2025 systematic review in HSS Journal analyzed its emerging use in sports medicine
Plant Mol Biol 21(5):923927
Immunogenicity: A notable proportion of patients (approximately 70 % or more) may develop low-titer antibodies to sermorelin with chronic use
Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Ted Brown W et al
These encompass transient erythema, stinging, minor pruritus, and xerosis, particularly at elevated concentrations or on thin or impaired skin
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
